Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Lipid-lowering therapy after coronary artery bypass surgery: the Post-CABG trial.

Stewart WJ, Hoogwerf BJ.

Cleve Clin J Med. 1997 Jul-Aug;64(7):347-51.

PMID:
9223762
2.

The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.

Post Coronary Artery Bypass Graft Trial Investigators.

N Engl J Med. 1997 Jan 16;336(3):153-62. Erratum in: N Engl J Med 1997 Dec 18;337(25):1859.

3.

Is aggressive cholesterol control justified? Review of the post-coronary artery bypass graft trial.

Hunninghake DB.

Am J Cardiol. 1998 Nov 26;82(10B):45T-48T. Review.

PMID:
9860374
5.

Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trial.

White CW, Gobel FL, Campeau L, Knatterud GL, Forman SA, Forrester JS, Geller NL, Herd JA, Hickey A, Hoogwerf BJ, Hunninghake DB, Rosenberg Y, Terrin ML; Post Coronary Artery Bypass Graft Trial Investigators.

Circulation. 2001 Nov 27;104(22):2660-5.

7.

Prevention of atherosclerosis in coronary-artery bypass grafts.

Fuster V, Vorchheimer DA.

N Engl J Med. 1997 Jan 16;336(3):212-3. No abstract available.

PMID:
8988902
8.

Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery.

Shah SJ, Waters DD, Barter P, Kastelein JJ, Shepherd J, Wenger NK, DeMicco DA, Breazna A, LaRosa JC.

J Am Coll Cardiol. 2008 May 20;51(20):1938-43. doi: 10.1016/j.jacc.2007.12.054.

9.

Moderate alcohol consumption and safety of lovastatin and warfarin among men: the post-coronary artery bypass graft trial.

Mukamal KJ, Smith CC, Karlamangla AS, Moore AA.

Am J Med. 2006 May;119(5):434-40.

PMID:
16651056
10.

Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial Investigators.

Campeau L, Hunninghake DB, Knatterud GL, White CW, Domanski M, Forman SA, Forrester JS, Geller NL, Gobel FL, Herd JA, Hoogwerf BJ, Rosenberg Y.

Circulation. 1999 Jun 29;99(25):3241-7.

11.

Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial.

Hoogwerf BJ, Waness A, Cressman M, Canner J, Campeau L, Domanski M, Geller N, Herd A, Hickey A, Hunninghake DB, Knatterud GL, White C.

Diabetes. 1999 Jun;48(6):1289-94.

PMID:
10342818
12.

Pleiotropic effect of lovastatin, with and without cholestyramine, in the post coronary artery bypass graft (Post CABG) trial.

Domanski M, Tian X, Fleg J, Coady S, Gosen C, Kirby R, Sachdev V, Knatterud G, Braunwald E.

Am J Cardiol. 2008 Oct 15;102(8):1023-7. doi: 10.1016/j.amjcard.2008.05.053. Epub 2008 Aug 9.

PMID:
18929703
13.

Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators.

Knatterud GL, Rosenberg Y, Campeau L, Geller NL, Hunninghake DB, Forman SA, Forrester JS, Gobel FL, Herd JA, Hickey A, Hoogwerf BJ, Terrin ML, White C.

Circulation. 2000 Jul 11;102(2):157-65.

14.

"The lower the better" in hypercholesterolemia therapy: a reliable clinical guideline?.

Jacobson TA.

Ann Intern Med. 2000 Oct 3;133(7):549-54. Review.

PMID:
11015169
15.

Effect of cholesterol lowering and cardiovascular risk factors on the progression of aortoiliac arteriosclerosis: a quantitative cineangiography study.

Campeau L, Lespérance J, Bilodeau L, Fortier A, Guertin MC, Knatterud GL.

Angiology. 2005 Mar-Apr;56(2):191-9.

PMID:
15793608
16.

Prognostic factors for atherosclerosis progression in saphenous vein grafts: the postcoronary artery bypass graft (Post-CABG) trial. Post-CABG Trial Investigators.

Domanski MJ, Borkowf CB, Campeau L, Knatterud GL, White C, Hoogwerf B, Rosenberg Y, Geller NL.

J Am Coll Cardiol. 2000 Nov 15;36(6):1877-83.

17.

Alcohol consumption, atherosclerotic progression, and prognosis among patients with coronary artery bypass grafts.

Mukamal KJ, Girotra S, Mittleman MA.

Am Heart J. 2006 Feb;151(2):368-72.

PMID:
16442902
18.

Aggressive lipid-lowering therapy beneficial after bypass grafting, say researchers.

[No authors listed]

Am J Health Syst Pharm. 1997 Mar 15;54(6):626. No abstract available.

PMID:
9075489
19.

The relationship between obesity and atherosclerotic progression and prognosis among patients with coronary artery bypass grafts the effect of aggressive statin therapy.

Wee CC, Girotra S, Weinstein AR, Mittleman MA, Mukamal KJ.

J Am Coll Cardiol. 2008 Aug 19;52(8):620-5. doi: 10.1016/j.jacc.2008.05.021.

20.
Items per page

Supplemental Content

Write to the Help Desk